European Association of Urology
Guidelines
Education & Events
Join our events Join our events
On-demand education Learn at your own pace
Scholarships Enrich your capabilities
Exchange Programmes Urology beyond Europe
Education Educational Platforms Talent Incubator Programme Accreditation
Science & Publications
Publications Our publications
Research & Science Passionate about research?
About
Who we are Our mission and history
Our Board and Offices How we work
Join the EAU Find out about membership
Vacancies Contact
Guidelines

Management of Non-neurogenic Male LUTS

Want to read the guideline in your own time? Download the PDF

Download full guideline

Looking for a quick overview? Check the pocket guidelines.

Download pocket guidelines
Full text guidelineSummary of ChangesPublications & AppendicesPanelRelated content
No results found
  1. Introduction
  2. Methods
  3. Epidemiology Aetiology And Pathophysiology
  4. Diagnostic Evaluation
  5. Disease Management
  6. Follow Up
  7. References
  8. Conflict Of Interest
  9. Citation Information
  10. Copyright And Terms Of Use
2. Methods
  • 1. Introduction
  • 2. Methods
  • 3. Epidemiology Aetiology And Pathophysiology
  • 4. Diagnostic Evaluation
  • 5. Disease Management
  • 6. Follow Up
  • 7. References
  • 8. Conflict Of Interest
  • 9. Citation Information
  • 10. Copyright And Terms Of Use
  • No elements found. Consider changing the search query.
  • List is empty.

2. METHODS

2.1. Introduction

For the 2024 EAU Guidelines on Non-Neurogenic Male LUTS, incl. BPO, new and relevant evidence was identified, collated and appraised through a structured assessment of the literature. A broad and comprehensive literature search, covering all sections of the Non-Neurogenic Male LUTS Guidelines was performed. The search was limited to studies representing high levels of evidence, i.e., systematic reviews (SR) with meta-analysis, randomised controlled trials (RCTs), and prospective non-randomised comparative studies, published in the English language. Databases searched included Medline, EMBASE, and the Cochrane Libraries, covering a time frame between May 1st 2021 and May 1st 2023. A total of 3,608 unique records were identified, retrieved and screened for relevance.

Detailed search strategies for the 2024 guideline are available online: http://www.uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/supplementary-material.

Recommendation within the Guidelines are developed by the panels to prioritise clinically important care decisions. The strength of each recommendation is determined by the balance between desirable and undesirable consequences of alternative management strategies, the quality of the evidence (including certainty of estimates), and the nature and variability of patient values and preferences. This decision process, which can be reviewed in the strength rating forms which accompany each guideline statement, addresses a number of key elements:

  1. the overall quality of the evidence which exists for the recommendation [1];
  2. the magnitude of the effect (individual or combined effects);
  3. the certainty of the results (precision, consistency, heterogeneity and other statistical or study related factors);
  4. the balance between desirable and undesirable outcomes;
  5. the impact and certainty of patient values and preferences on the intervention.

Strong recommendations typically indicate a high degree of evidence quality and/or a favourable balance of benefit to harm and patient preference. Weak recommendations typically indicate availability of lower quality evidence, and/or equivocal balance between benefit and harm, and uncertainty or variability of patient preference [2].

Additional methodology information and a list of associations endorsing the EAU Guidelines can be found in the online: https://uroweb.org/eau-guidelines/methodology-policies.

2.2. Review

The Non-Neurogenic Male LUTS Guidelines were peer reviewed prior to publication in 2016. The newly added section on underactive bladder in males was peer reviewed prior to the publication in 2024.

2.3. Patients to whom the guidelines apply

Recommendations apply to men who seek professional help for LUTS in various non-neurogenic and non-malignant conditions such as BPO, detrusor overactivity (DO)/overactive bladder (OAB), urinary incontinence, and/or nocturnal polyuria. Specific context usually requires a more extensive work-up e.g., concomitant neurological diseases, young age, prior LUT disease or surgery, which is not covered in these Guidelines, but may include several tests mentioned in the following sections. EAU Guidelines on Neuro-Urology, Urological Infections, Urolithiasis, or malignant diseases of the LUT have been developed by other EAU Guidelines Panels and are available online: www.uroweb.org/guidelines/.

About EAU
  • Who we are
  • How we work
  • Become a member
Services
  • MyEAU
  • Congress registrations
  • Abstract submission
Media
  • EAU News
  • EAU Newsletter
  • EAU Press Releases
Contact
  • EAU Central Office
    PO Box 30016
    NL-6803 AA ARNHEM
    The Netherlands

  • Contact us
About EAU
Who we areHow we workBecome a member
Services
MyEAUCongress registrationsAbstract submission
Media
EAU NewsEAU NewsletterEAU Press Releases
Contact

EAU Central Office
PO Box 30016
NL-6803 AA ARNHEM
The Netherlands

Contact us
European Association of Urology
Privacy PolicyDisclaimer